The United States is joining with Europe and Australia in coordinating inspections of factories in China and India that produce raw materials for drugs. According to U.S. officials, this will allow regulators to cover a bigger territory. The pilot program will focus first on facilities in China and India. Contaminated heparin, made from Chinese ingredients, has been linked to dozens of deaths and hundreds of allergic reactions. The blood thinner drug has been recalled by Baxter International and the U.S. has blocked imports from the Chinese company. Health and Human Services Secretary Mike Leavitt now says there is a pressing need for new tools to deal with changes in the global market. I have to wonder why it took him so long to come to this conclusion. Surely, he has to know that China had been a serious importer of products to the U.S.
Source: Associated Press
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.